Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Inv. presentation
Appointed director
|
|
MARIZYME, INC. (MRZM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/14/2018 |
8-K
| Resignation/termination of a director|
Docs:
|
"Marizyme, Inc., Appoints New Members to its Board of Directors FORT COLLINS, CO, December 14, 2018 — Marizyme, Inc. , a publicly traded company focusing on acquiring late-stage drug assets for use in the acute care space for development and commercialization, announced today that it is appointing Mr. James Sapirstein and Mr. Terry Brostowin to the Board of Directors. In addition, the Company has accepted the resignation of Mr. Juan Francisco Gutierrez from the Board of Directors, for health reasons, and the resignation of Mr. Marco Nicolaides as the Company’s Treasurer. The Company is very grateful to Mr. Gutierrez and Mr. Nicolaides for their service to the Company and their leadership during his term. Mr. Sapirstein, who has been appointed Executive Chairman, is a highly-regarded pharmac..." |
|
| 05/16/2014 |
8-K
| Quarterly results |
|
|